By Michael Mulvey on February 11, 2014 9:52 AM
We often hear about new products that promise to beat the current market leader by being the "blah blah blah on steroids".
I'm not a big fan of this strategy.
That doesn't mean that the market leader isn't vulnerable but it's a question of the approach.
Apple didn't put a hurt on Microsoft desktop business by a better version of Mac OS. They put the hurt by nailing a new category altogether with the iPad.
By contrast Microsoft has adopted the "on steroids" strategy in many of their products.
The Surface tablet is an attempt to be an "iPad on steroids". It has a keyboard, it shipped with a pro and consumer model. It can do split screen. The list goes on.
You know how well the Surface did.
via Marco Arment